.png)
.png)
$89
Unlimited access to therapy
Participation in group classes
Unlimited access to therapy
Access to equipment
$129
Unlimited access to therapy
Participation in group classes
Unlimited access to therapy
Access to equipment
active lifestyle with our expert care
active lifestyle with our expert care
Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive treatment that uses targeted magnetic pulses to stimulate specific areas of the brain. These pulses activate nerve cells involved in mood regulation. In people experiencing depression, this part of the brain can show reduced activity. By repeatedly stimulating this area, rTMS can help improve brain function and support relief from depressive symptoms.
During an rTMS session, you will sit in a comfortable chair while wearing earplugs to reduce the sound produced by the device. A trained technician will place the rTMS coil against your scalp to target the relevant brain region. Throughout the session, the device delivers magnetic pulses, which produce a tapping sound and sensation at intervals.
rTMS treatment is generally well tolerated and does not produce the common side effects often associated with antidepressant medications. Some people may notice mild scalp discomfort or a temporary headache during or after treatment. Most patients are able to return to their usual daily activities immediately following a session.
Individual rTMS sessions usually last between 6 and 20 minutes. The full treatment course commonly runs for around 2 to 6 weeks, with sessions scheduled daily depending on your personalised treatment plan.
Yes. A referral from a GP or psychiatrist is required before starting rTMS therapy. An initial assessment with a consultant psychiatrist will be conducted to determine whether rTMS is appropriate for you and to prescribe the treatment if suitable.
Medicare rebates may be available for rTMS treatment if certain eligibility criteria are met. This generally includes having a diagnosis of depression, not having previously received rTMS therapy, and having tried at least two different types of antidepressant medications without sufficient improvement.